It was shown that inhibition of the protein kinase SRPK1 reduces phosphorylation of the splicing factors SRSF1 and SRSF2, resulting in significant splicing dysregulation in AML cells. The gene discussed is SRPK1; the disease is acute myeloid leukemia.